Skip to content
Intergel

Intragel announces world leading physician, Professor Henry Brem, M.D. has joined its Advisory Board.

PROFESSOR HENRY BRENM, MD   Cushing Professor of Neurosurgery, Johns Hopkins University, USA

Intragel announces world leading physician, Professor Henry Brem, M.D. has joined its Advisory Board.

IntraGel selected as a showcase presentation at the upcoming LSX World Congress

IntraGel selected as a showcase presentation at the upcoming LSX World Congress.

Intragel announces its first head and neck cancer patient was treated with TumoCure injection, as part of its clinical trial phase 1b at Hadassah Medical Center in Israel

Intragel announces its first head and neck cancer patient was treated with TumoCure injection, as part of its clinical trial phase 1b at Hadassah Medical Center in Israel.

Intragel was featured in the CTech by Calcalist

Intragel was featured in the CTech by Calcalist

Intragel Receives Approval from the Ministry of Health for its Phase II/III GMP Facility Concept at the NGT Nazareth Incubator.

Intragel Receives Approval from the Ministry of Health for its Phase II/III GMP Facility Concept at the NGT Nazareth Incubator.

Intragel Welcomes Leading Healthcare Business Executives Zeev Zehavi, MBA and Nissim Darvish MD, DSc., to its Board of Directors

Intragel Welcomes Leading Healthcare Business Executives Zeev Zehavi, MBA and Nissim Darvish MD, DSc., to its Board of Directors.

Intragel Announces Expansion of its Head and Neck Cancer Trial to Samson Assuta Ashdod University Hospital in Israel

Intragel Announces Expansion of its Head and Neck Cancer Trial to Samson Assuta Ashdod University Hospital in Israel.

Intragel Welcomes Dr. Jorge J Nieva to its Scientific Advisory Board

DR. JORGE J NIEVA Associate Professor of Clinical Medicine, Keck School of Medicine at USC

Intragel Welcomes Dr. Jorge J Nieva to its Scientific Advisory Board.

Intragel Expands Compassionate Use Program in Medias Klinikum to New Cancer Indications

Medias Klinikum

Intragel Expands Compassionate Use Program in Medias Klinikum to New Cancer Indications.

Intragel
Follow us on Linkedin
Follow us on Linkedin

Intragel is a biotechnology company developing the SRGel™ long-acting injectable (LAI) platform for small molecules, peptides, and biologics. Designed for controlled, extended release from a single administration, SRGel™ delivers sustained therapeutic exposure with minimal dosing frequency.

Contact Us

info@intra-gel.com
+972-4-6098606
Nazareth Industrial Area Wadi El Haj 13 P.O.Box 1252 Nazareth, 17111 Israel
Copyright 2026 © Intragel
Privacy policy | Terms of use | All rights reserved

Website branding & design by Joya Marketing